Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
04/06/2026 02:08
BRIEF-Racura Oncology Says Emerging Companies Specialist Invests In Racura June 4 (Reuters) - Racura Oncology Ltd RAC.AX:
EMERGING COMPANIES SPECIALIST INVESTS IN RACURA
PLACEMENT OF 526,315 FULLY PAID ORDINARY SHARES AT ISSUE PRICE OF A$1.90 PER SHARE
PLACEMENT, COMBINED WITH FUNDS FROM PIGGYBACK AND BONUS OPTIONS, RAISED A$31.2 MILLION TO SUPPORT CLINICAL DEVELOPMENT OF RC220
Further company coverage: RAC.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Racura Oncology
See all newsAustralia's Racura Oncology jumps most in a month after raising $24 million
Brief: Racura Oncology Says Emerging Companies Specialist Invests In Racura
Brief: Racura Oncology Announces Positive Safety Review Committee Recommendation In Ongoing Cpacs Clinical Trial
Australia's Racura Oncology gains on Purdue University cancer study collab
Brief: Racura Oncology Receives Governance Approval For Harness-1 Phase 1 Trial Of Rc220